Enovis Corp logo

Enovis Corp (C520)

Market Open
2 Jun, 20:00
XDUS XDUS
18. 50
-0.5
-2.6316%
- Market Cap
- P/E Ratio
- Div Yield
0 Volume
- Eps
19
Previous Close
Add Transaction
Day Range
17.9 18.5
Year Range
17.6 30.8
Want to track C520 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

C520 trading today lower at €18.5, a decrease of -2.6316% from yesterday's close, completing a monthly decrease of -7.0352% or -€1.4. Over the past 12 months, C520 stock lost -17.4107%.
C520 is not paying dividends to its shareholders.
The last earnings report, released on May 06, 2026, exceeded the consensus estimates by 0%. On average, the company has fell short of earnings expectations by -0.2377%, based on the last three reports.
Enovis Corp has completed 1 stock splits, with the recent split occurring on Apr 05, 2022.
The company's stock is traded on 6 different exchanges and in various currencies, with the primary listing on NYSE (USD).

C520 Chart

Does Enovis (ENOV) Have the Potential to Rally 65.45% as Wall Street Analysts Expect?

Does Enovis (ENOV) Have the Potential to Rally 65.45% as Wall Street Analysts Expect?

The average of price targets set by Wall Street analysts indicates a potential upside of 65.5% in Enovis (ENOV). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

Zacks | 3 weeks ago
Enovis Q1 Earnings Call Highlights

Enovis Q1 Earnings Call Highlights

Enovis NYSE: ENOV reported a solid start to 2026, with management pointing to share gains in its reconstructive surgery business, stable growth in prevention and recovery, and continued investment in new products including ARVIS and Nebula.

Marketbeat | 3 weeks ago
Enovis Corporation (ENOV) Q1 2026 Earnings Call Transcript

Enovis Corporation (ENOV) Q1 2026 Earnings Call Transcript

Enovis Corporation (ENOV) Q1 2026 Earnings Call Transcript

Seekingalpha | 3 weeks ago

Enovis Corp (C520) FAQ

What is the stock price today?

The current price is €18.50.

On which exchange is it traded?

Enovis Corp is listed on XDUS.

What is its stock symbol?

The ticker symbol is C520.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, no market cap data is available.

Has Enovis Corp ever had a stock split?

Enovis Corp had 1 splits and the recent split was on Apr 05, 2022.

Enovis Corp Profile

Machinery Industry
Industrials Sector
Damien McDonald CEO
XDUS Exchange
US1940145022 ISIN
US Country
7,367 Employees
- Last Dividend
5 Apr 2022 Last Split
- IPO Date

Overview

Enovis Corporation, a notable entity in the medical technology landscape, operates on a global scale. It specializes in the development, manufacture, and distribution of a varied portfolio of medical device products. These products are designed to cater to the needs of orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and a broad spectrum of other healthcare professionals. The primary focus of the company is to provide solutions for patients suffering from musculoskeletal conditions that arise due to degenerative diseases, deformities, traumatic events, and sports-related injuries. Initially known as Colfax Corporation, Enovis Corporation has rooted its headquarters in Wilmington, Delaware, illustrating a significant presence in the medical technology domain.

Products and Services

Enovis Corporation delivers an extensive array of products and services across the medical technology field:

  • Rigid and Soft Orthopedic Bracings: These are designed to support and immobilize various parts of the body to assist with the healing process of musculoskeletal issues.
  • Hot and Cold Therapy Products: Utilized for pain relief and reducing inflammation, these therapy products play a crucial role in both acute and chronic injury management.
  • Bone Growth Stimulators: Aimed at enhancing the healing process of bones, these devices are especially beneficial for patients experiencing slow healing in fractures and other bone-related conditions.
  • Vascular Therapy Systems and Compression Garments: These products are intended to improve blood circulation, reduce swelling, and enhance the recovery process in patients with vascular issues or those recovering from surgery.
  • Therapeutic Shoes and Inserts: Designed for individuals suffering from foot-related conditions, these products help in reducing pain and enhancing mobility.
  • Electrical Stimulators for Pain Management: These devices are used in the treatment of pain, employing electrical stimulation to relieve chronic and acute musculoskeletal pain.
  • Physical Therapy Products: A broad range of products supporting physical therapy practices, including exercise equipment and tools for rehabilitation and strengthening.
  • Reconstructive Joint Products: Offering a suite of products for the hip, knee, shoulder, elbow, foot, ankle, and fingers, these items are integral for joint reconstruction surgeries and treatments.

Moreover, Enovis Corporation markets its cutting-edge products through a combination of independent distributors, including healthcare professionals, consumer retail stores, and pharmacies, and directly to consumers under the notable DJO brand. This strategic approach allows the company to span a wide market, reaching various healthcare providers and patients efficiently.

Contact Information

Address: 2711 Centerville Road
Phone: 302 252 9190